Conjupri® (levamlodipine) – New drug approval
December 20, 2019 - CSPC Pharmaceutical Group announced the FDA approval of Conjupri (levamlodipine), for the treatment of hypertension in adults and pediatric patients 6 years and older, to lower blood pressure.
Download PDF
